We are live on
!
Find out more
BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.97B
1-Year Est. Return
44.96%
This Fund
S&P 500
This Quarter
Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
(-15%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-11.83%
Top 10 Holdings %
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$13.9M |
| 2 |
Cleveland-Cliffs
CLF
|
+$13.6M |
| 3 |
Tapestry
TPR
|
+$13.4M |
| 4 |
Automatic Data Processing
ADP
|
+$12.2M |
| 5 |
Ford
F
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$18.8M |
| 2 |
Waters Corp
WAT
|
+$15.6M |
| 3 |
Cummins
CMI
|
+$15.3M |
| 4 |
Cigna
CI
|
+$15.1M |
| 5 |
Ameriprise Financial
AMP
|
+$13.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.38% |
| 2 | Energy | 11.53% |
| 3 | Industrials | 10.56% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Technology | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Minerva Neurosciences
NERV
$199M
| $149K | ﹤0.01% |
16,148
| – | – |
|
1202
Ocean Power Technologies
OPTT
$49.9M
| $148K | ﹤0.01% |
+180,000
| New | +$168K |
|
1203
Cabaletta Bio
CABA
$455M
| $147K | ﹤0.01% |
225,951
-28,601
| -11% | -$34.4K |
|
|
VAXX
1204
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $147K | ﹤0.01% |
+74,400
| New | +$155K |
|
1205
Quince Therapeutics
QNCX
$29.5M
| $146K | ﹤0.01% |
+550
| New | +$209K |
|
|
SONX
1206
DELISTED
Sonendo, Inc.
SONX
| $146K | ﹤0.01% |
136,500
-20,000
| -13% | -$29.1K |
|
1207
National CineMedia
NCMI
$378M
| $145K | ﹤0.01% |
22,200
+2,200
| +11% | +$26.5K |
|
1208
Travelzoo
TZOO
$75.4M
| $145K | ﹤0.01% |
32,643
-20,000
| -38% | -$117K |
|
|
IVC
1209
DELISTED
Invacare Corporation
IVC
| $145K | ﹤0.01% |
185,496
-10,000
| -5% | -$10.5K |
|
1210
Aware
AWRE
$27.7M
| $144K | ﹤0.01% |
80,679
| – | – |
|
1211
Hyperfine
HYPR
$101M
| $142K | ﹤0.01% |
175,000
+25,000
| +17% | +$35.3K |
|
1212
Key Tronic
KTCC
$44.7M
| $141K | ﹤0.01% |
34,800
| – | – |
|
1213
Westwater Resources
WWR
$97.5M
| $141K | ﹤0.01% |
123,700
| – | – |
|
1214
Splash Beverage Group
SBEV
$2.72M
| $140K | ﹤0.01% |
639
-282
| -31% | -$107K |
|
1215
Protalix BioTherapeutics
PLX
$198M
| $139K | ﹤0.01% |
133,790
-25,000
| -16% | -$27.7K |
|
1216
Solid Biosciences
SLDB
$900M
| $138K | ﹤0.01% |
19,687
| – | – |
|
1217
ThredUp
TDUP
$422M
| $138K | ﹤0.01% |
+75,000
| New | +$188K |
|
1218
Backblaze
BLZE
$1.16B
| $137K | ﹤0.01% |
27,500
| – | – |
|
1219
Stereotaxis
STXS
$141M
| $137K | ﹤0.01% |
+76,200
| New | +$163K |
|
|
PVLA
1220
Palvella Therapeutics
PVLA
$2.27B
| $134K | ﹤0.01% |
1,456
-1,208
| -45% | -$156K |
|
1221
Dyne Therapeutics
DYN
$4.9B
| $132K | ﹤0.01% |
10,400
-6,000
| -37% | -$68.8K |
|
|
LHDX
1222
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $132K | ﹤0.01% |
124,700
+37,000
| +42% | +$84.3K |
|
|
DS
1223
DELISTED
Drive Shack Inc.
DS
| $131K | ﹤0.01% |
210,500
-102,800
| -33% | -$123K |
|
1224
Corvus Pharmaceuticals
CRVS
$1.17B
| $130K | ﹤0.01% |
159,300
| – | – |
|
1225
Gain Therapeutics
GANX
$77.6M
| $130K | ﹤0.01% |
40,000
| – | – |
|
Similar funds
SNT
MA
FFB
AM
SGM
PAMP
SMFG
SIA
Bridgeway Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.
Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.
- Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
- Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
- Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
- Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
- Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
- Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
- Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.
Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.